Questions: Protist Classification and Parasitic Protists

Question 1

A patient with African sleeping sickness produces antibodies that successfully clear Trypanosoma brucei parasites, reducing parasitemia. Three weeks later, parasitemia returns. An antibody test shows the returning parasites are coated with a completely different surface protein than the original wave. What mechanism explains this?

• A. The patient's immune system failed to generate sufficient antibody titers to fully clear the infection
• B. Trypanosoma brucei forms dormant cysts that re-emerge after the initial immune response wanes
• C. Trypanosoma switches which variant surface glycoprotein (VSG) gene it expresses, creating a new surface coat that existing antibodies cannot recognize
• D. The parasite mutates rapidly under immune pressure, generating novel surface antigens through point mutation

Answer: (C)

Antigenic variation in Trypanosoma is not driven by random mutation but by programmed gene switching. The parasite's genome encodes over 1,000 different VSG genes, and it periodically switches which one is expressed from a dedicated expression site. When the host immune system clears one VSG-coated population, a subpopulation that had already switched to a new VSG escapes and expands, producing the next wave of parasitemia. This is a pre-existing toolkit, not an evolutionary response to immune pressure — switching occurs constitutively, creating the characteristic peaks and troughs of sleeping sickness.

Question 2

Why are complex multi-stage life cycles — like Plasmodium's progression through distinct forms in the mosquito midgut, salivary glands, human liver, and red blood cells — characteristic of parasitic protists but extremely rare among parasitic bacteria?

• A. Protists are multicellular organisms with specialized cells for each life stage, while bacteria are unicellular
• B. Bacteria cannot infect vertebrate hosts because they are recognized and destroyed immediately by innate immunity
• C. Protists possess the full eukaryotic cellular machinery — nucleus, endomembrane system, cytoskeleton, meiotic division — enabling the morphological differentiation and surface remodeling that distinct life-cycle stages require
• D. Parasitic bacteria have simpler but equally effective immune evasion strategies that eliminate the need for life-cycle complexity

Answer: (C)

Multi-stage life cycles require the ability to radically change cell morphology, surface protein composition, and metabolic program. This depends on regulated gene expression, endomembrane trafficking for surface remodeling, cytoskeletal reorganization, and in some cases, meiosis for sexual stages. These capabilities are properties of the eukaryotic cell. Bacteria have sophisticated immune evasion strategies, but they cannot execute the kind of wholesale morphological and metabolic transformation that produces the sporozoite-to-merozoite transition in Plasmodium. Option A is wrong — protists are unicellular (or colonial); their complexity is cellular, not multicellular.

Question 3

Protist classification by locomotion type (flagellates, ciliates, amoeboids) accurately reflects the evolutionary relationships among protists, grouping related organisms together based on shared ancestry.

• T. True
• F. False

Answer: False

Locomotion-based classification is convenient for identification and historically important, but modern molecular phylogenetics has shown that organisms sharing the same locomotion mode are often not closely related. For example, flagella have evolved independently multiple times; 'flagellates' is not a monophyletic group. Modern protist classification is based on molecular phylogenies that often produce counterintuitive groupings — organisms that look very different may be closely related, and similar-looking organisms may be evolutionary distant. The traditional locomotion scheme survives in clinical and introductory contexts but should not be interpreted as reflecting evolutionary history.

Question 4

Leishmania species survive inside macrophages — the very cells designed to destroy them — by actively inhibiting phagolysosome acidification, exploiting their eukaryotic cellular complexity to subvert the host's primary defense mechanism.

• T. True
• F. False

Answer: True

This is one of the most striking examples of how eukaryotic cellular complexity enables sophisticated pathogenic strategies. Macrophages normally kill engulfed pathogens by fusing lysosomes with the phagosome, acidifying the compartment and activating degradative enzymes. Leishmania inhibits this fusion or prevents acidification, creating a protected niche inside the very cell meant to destroy it. The molecular mechanisms involve parasite-derived phosphatases and kinases that interfere with host vesicle trafficking — a level of cellular regulatory sophistication that simple bacterial pathogens cannot easily replicate.

Question 5

Explain how antigenic variation in Trypanosoma brucei works, and why it makes the parasite so difficult for the immune system to eliminate even with a robust antibody response.

Model answer: Trypanosoma brucei coats its entire surface with a dense layer of a single variant surface glycoprotein (VSG). The parasite's genome encodes over 1,000 different VSG genes, but only one is expressed at a time from a specialized expression site. The parasite periodically switches which VSG gene is expressed. When the host immune system generates antibodies against the current VSG and begins clearing that population, a small subpopulation has already switched to a new VSG that the existing antibodies cannot recognize. This subpopulation expands, producing the next wave of parasitemia. Because switching is continuous and the VSG repertoire is vast, the immune system can never fully eliminate the parasite — each wave is antigenically novel.

The result is the characteristic wave pattern of African sleeping sickness: peaks and troughs of parasitemia as successive antibody responses clear one VSG-coated population, only for the next to emerge. Without treatment, this continues until the parasite crosses the blood-brain barrier and causes the neurological symptoms that give the disease its name. The strategy is only possible for a eukaryote with the gene regulatory machinery to orchestrate precise, programmatic switching between hundreds of genes.